fda semaglutide update 📢 has determined the shortage of injection products, a glucagon-like peptide 1 (GLP-1) medication, is resolved. Patients and prescribers may still see intermittent and limited localized supply disruptions as the FDA alerts health care providers,

After a surprise contest with Novo Nordisk in October over its plans to acquire Metsera, the pharmaceutical giant won out in November to seal the deal for the biopharma company

95% CI, 0.68-1), low-range prediabetes (HR = 0.77

Yes, especially when the irregularity is linked to insulin resistance, PCOS, stress or nutrient gaps

Long term data needs to be evaluated to truly understand the impact of the GLP receptor drugs

Regular Movement: Consistent, moderate exercise has been shown to boost the bodys internal antioxidant defenses, though it is important not to overtrain, as excessive physical stress can temporarily deplete your levels